Question · asked by 1 review
Lamotrigine vs valproate: 50% or greater reduction in seizure frequency
- Population
- absence seizures in children and adolescents
- Intervention
- Lamotrigine
- Comparison
- valproate
- Outcome
- 50% or greater reduction in seizure frequency
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Lamotrigine vs valproate 50% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents The review found no eligible studies for this question. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Lamotrigine vs phenobarbital · patients with AD and epileptic seizures · 1 review
- Lamotrigine vs placebo · people with drug‐resistant focal epilepsy · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.